Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/13/16 → 6/12/19 |
Funding
- Sunovion Pharmaceuticals Incorporated: $508,405.00
SB-STR02: A Double-Blind, Controlled Phase 2B Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients with Chronic Motor Deficit from Ischemic Stroke
- van Horne, Craig (PI)
- Quintero, Jorge (CoI)